Marvel Rivals Will Fire Up Closed Beta On PC And Consoles Next Month, Sign Ups Open
North America, Europe, and Asia players are all invited to sign up.
We've got the next testing dates for the upcoming Netease hero shooter Marvel Rivals. If you live in North America, Europe, or Asia and you want to try to get in on some testing, you can sign up now via a questionnaire if you're on consoles, and via a Steam Request if you plan to play on PC.
The closed beta will start on July 23rd and run for about two weeks ending on August 5th. A total of 21 characters will be available to test including Magneto, Spider-Man, and Venom amongst others. We'll see 5 different maps in the test and Convoy, Domination, and Convergence will be the modes you'll be testing.
While you can fill out the console questionnaire now, you won't be able to sign up for Steam access until July 20th. On the plus side, the team will start sending invites the same day sign ups open up, so if you get access you won't have to wait long to know that. Similar to previous, smaller testing phases, the Marvel Rivals team will be sending out additional invites throughout the test to expand the number of players as the test progresses.
Related Articles
About the Author
Mike “Magicman” Byrne has been a part of the MMOBomb family for years and serves as the site’s current Editor-in-Chief. His love for MMOs and gaming in general has led him to covering games for numerous gaming websites including Gamebreaker TV and XIV Nation where he proudly displays his fanboy flag for FFXIV:ARR.
More Stories by Michael ByrneRead Next
Preview Some Of The First Descendant's Characters So You Know Who To Play When It Launches Next Week
Electricity, Barriers, Water... get a look at 3 of the shooter's character gameplay trailers.
You May Enjoy
The PS5 version has a mode for you PS5 Pro users, too.
It's a neat walk down memory lane checking out where some Warframe features started.
The new weapon is made for almost any playstyle.
Sprouts and Sages offers new ways to help new players.
Discussion (0)